Health Sciences Group, Inc.
HESG · OTC
12/31/2012 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Market Cap | $0 | $9,578 | $9,888 | $15,208 |
| - Cash | $1 | $21 | $241 | $121 |
| + Debt | $320 | $335 | $1,037 | $872 |
| Enterprise Value | $319 | $9,892 | $10,684 | $15,960 |
| Revenue | $358 | $60 | $67 | $5,365 |
| % Growth | 496% | -10.5% | -98.7% | – |
| Gross Profit | $25 | $23 | $47 | $998 |
| % Margin | 7% | 38.1% | 69.4% | 18.6% |
| EBITDA | -$45 | -$4,970 | -$3,285 | -$2,324 |
| % Margin | -12.5% | -8,263.8% | -4,888.1% | -43.3% |
| Net Income | -$54 | -$5,750 | -$10,452 | -$7,419 |
| % Margin | -15.2% | -9,560.7% | -15,552.6% | -138.3% |
| EPS Diluted | -0.029 | -0.25 | -0.78 | -0.76 |
| % Growth | 88.4% | 67.9% | -2.6% | – |
| Operating Cash Flow | $42 | -$3,739 | -$1,054 | -$1,145 |
| Capital Expenditures | -$0 | -$360 | -$3 | -$94 |
| Free Cash Flow | $42 | -$4,099 | -$1,057 | -$1,239 |